Clinical trial
Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors
NCT00447005 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00447005 |
|---|---|
| Title | Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors |
| Official title | A Phase 1 Study Of AG-013736 (Axitinib) In Japanese Patients With Advanced Solid Tumors |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma |
| Intervention type | Drug |
| Interventions | Axitinib (AG-013736) |
| Enrollment | 12 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Mar 13, 2007 |
| Last update posted | May 23, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: